Reata Pharmaceuticals Inc.
shares surged after hours Monday as the biotech company announced positive results from a clinical trial for a neuromuscular disorder treatment. Reata shares, which had been halted after hours, surged 33% in the extended session, after closing up 5% at $100.59 in Monday trading for a market cap of just over $3 billion.
why?
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: